@article{0adaf13857ae4b32bf4b985e2682fb6f,
title = "Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) (Journal of Neuro-Oncology, (2019), 143, 3, (573-581), 10.1007/s11060-019-03194-z)",
abstract = "The last author's first name was truncated in the initial online publication. The original article has been corrected.",
author = "Jaeckle, {Kurt A.} and Anderson, {S. K.} and Twohy, {Erin L.} and Dixon, {Jesse G.} and Caterina Giannini and Robert Jenkins and Egorin, {Merrill J.} and Sarkaria, {Jann N.} and Brown, {Paul D.} and Flynn, {P. J.} and John Schwerkoske and Buckner, {Jan C.} and Evanthia Galanis",
note = "Publisher Copyright: {\textcopyright} 2019, Springer Science+Business Media, LLC, part of Springer Nature.",
year = "2019",
month = jul,
day = "1",
doi = "10.1007/s11060-019-03201-3",
language = "English (US)",
volume = "143",
pages = "583",
journal = "Journal of neuro-oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",
}